TriNetX, a global health research network that revolutionizes clinical research and enables discoveries through the generation of real-world evidence (RWE) has acquired Belgium-based Custodix NV and its InSite network. InSite network is a European-based provider of services for clinical trial design, patient feasibility, and enabling workflow for patient recruitment. Financial details of the acquisition were not disclosed.
InSite Clinical Data Network Background
The InSite platform is an
Read More
Novartis
Digital Prescribing Platform Xealth Raises $11M to Expand Digital Health Tools
Xealth, a Seattle-based digital prescribing platform has raised $11 million in Series A funding from McKesson Ventures, Novartis, Philips, and ResMed. Existing investors Threshold Ventures (formerly DFJ Venture), Providence Ventures, UPMC and Froedtert and the Medical College of Wisconsin health network also participated in the round.Xealth BackgroundSpun out of Providence St. Joseph Health in 2017, Xealth enables clinicians to prescribe and monitor digital healthcare content, apps, devices, and
Read More
Novartis, SHYFT Partner to Support the Commercialization of Key Therapies in Europe
SHYFT Analytics, a Medidata Solutions, today announced that Novartis has selected its Intelligent Platform for Life Sciences to support the commercialization of key therapies in Europe. As part of the collaboration, Novartis will use the following SHYFT solutions: - STRATA Data Platform to aggregate and manage a growing number of third party and proprietary commercial data sources- LUMEN Insights Platform to deliver intuitively-designed analytics to drive the “next-best-actions” for commercial
Read More
Novartis to Acquire Gene Therapy Provider AveXis for $8.7B in Cash
Novartis announced today that is has entered into an agreement to acquire AveXis, Inc., a clinical stage gene therapy company for $8.7 billion in cash. AveXis lead product candidate, AVXS-101, has potential to be first-ever one-time gene replacement therapy for spinal muscular atrophy (SMA), a disease which results in early death or lifelong disability with considerable healthcare costs. It is estimated that one out of every 6,000-10,000 children born is affected by some form of SMA.The US Food
Read More
GSK Acquires Novartis’ Consumer Healthcare Business for $13B
GlaxoSmithKline (GSK) has reached an agreement to acquire Novartis’ consumer healthcare joint venture for $13 billion. The acquisition will enable GSK’s shareholders to capture the full value of GSK’s Consumer Healthcare growth and is well positioned to deliver sales growth, operating margin improvements and attractive returns.Upon terms of the agreement, India remains a priority market for GSK investment and growth. The Consumer Healthcare business will continue to invest in growth
Read More
Novartis Selects Cota Healthcare’s Data Analytics Platform to Develop Therapies for Breast Cancer Patients
Novartis Pharmaceuticals Corporation has signed a multi-year agreement with Cota Healthcare, a data and technology platform for value-based precision medicine to help improve clinical and cost outcomes for breast cancer patients. As part of this multi-year agreement, Novartis will leverage Cota's research-grade, real-world evidence, web-based analysis and visualization tools, and be supported by Cota's medical, data science, and technology experts. Utilizing the real-world evidence and
Read More
Report: Life Sciences M&A and the Rise of Personalized Medicine
As the life sciences (pharmaceuticals, biotechnology and medical sectors) M&A reaches new heights, there seems to be no end in sight for life sciences companies' hunger for acquisitions. 94% of life sciences companies are planning to make an acquisition in the next year, with 91% of US respondents expecting these to be cross-border transactions, according to a global study of 100 senior executives at life sciences companies by global law firm Reed Smith, commissioned by Mergermarket.
The
Read More
20 Promising Canadian Digital Health Companies to Watch
“A company’s odds of success are better the closer they can get to their market,” argues Stephen Hurwitz, a thought leader in the Canadian venture capital industry, recognizing that the proximity to a VC-tech hub can help the success rate of Canadian startups.
A socialized healthcare system, Canada’s market is fragmented by province and type of care – most primary and emergency care is free for residents whereas specialty care, prescription drugs, long-term and in-home care amongst others,
Read More
